Log In
Friday 25th May 2018

Alzheimer's drug decision reversed

24th March 2011

The National Institute for Health and Clinical Excellence (NICE) has extended the use of three drugs to treat Alzheimer’s disease.

Aricept, exelon and reminyl are currently available through the NHS to sufferers of the condition who have moderate to severe symptoms but the drugs, which costs around £2.80 per patient per day, has now been approved for patients with milder problems. A fourth drug - ebixa - will be extended to people suffering more moderate symptoms after only previously being given to those in the late stages of the disease.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018